CLL patients with a deletion of NFKBIE, a negative regulator of NF-κB, show increased p65 phosphorylation and translocation, yet Bcl-XL gene expression is not significantly differently expressed39. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.